Hironobu Endo

Long-term safety and efficacy of patisiran for hereditary transthyretin-mediated amyloidosis with polyneuropathy: 12-month results of an open-label extension study

David Adams, Michael Polydefkis, Alejandra González‐Duarte et al. · The Lancet Neurology · 2020 · 154 citations · Full text

Alzheimer's Disease, Open-label Extension Study, Medicine +5

Association between Aβ and tau accumulations and their influence on clinical features in aging and Alzheimer's disease spectrum brains: A [¹¹C]PBB3‐PET study

Hitoshi Shimada, Soichiro Kitamura, Hitoshi Shinotoh et al. · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring · 2016 · 84 citations · Full text

Imaging α-synuclein pathologies in animal models and patients with Parkinson’s and related diseases

Hironobu Endo, Maiko Ono, Yuhei Takado et al. · Neuron · 2024 · 75 citations · Full text

In vivo binding of a tau imaging probe, [¹¹C]PBB3, in patients with progressive supranuclear palsy

Hironobu Endo, Hitoshi Shimada, Naruhiko Sahara et al. · Movement Disorders · 2019 · 47 citations · Full text

Vivo Binding, Neuropsychiatry, Neurochemical Biomarkers +22

Tau-induced focal neurotoxicity and network disruption related to apathy in Alzheimer’s disease

Soichiro Kitamura, Hitoshi Shimada, Fumitoshi Niwa et al. · Journal of Neurology Neurosurgery & Psychiatry · 2018 · 43 citations · Full text